Trial site
Chengdu
- 3running trials
- 0closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
The site has not confirmed any trial yet.
Running trials
Recruiting
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
Researchers
No researcher is linked here yet.
Site data: ClinicalTrials.govUpdated 6 Nov 2026